Novartis | Egenkapital Og Reserver

Equity Capital And Reserves Endring Dato
AbbVie USD 8.05B 4.05B 2024-03
Alcon AG USD 20.83B 203M 2024-03
Almirall EUR 1.48B 12.8M 2024-03
Amgen USD 5.02B 1.21B 2024-03
AstraZeneca USD 37.5B 1.64B 2024-03
Bayer EUR 35.76B 2.84B 2024-03
Biogen USD 15.21B 413.6M 2024-03
Bristol-Myers Squibb USD 16.55B 12.45B 2024-03
Eli Lilly USD 12.9B 1.68B 2024-03
Fresenius EUR 20.12B 1.12B 2024-03
Fresenius Medical Care EUR 15.13B 1.13B 2024-03
Galapagos EUR 2.9B 99.44M 2024-03
Genmab DKK 32.5B 887M 2024-03
Gilead Sciences USD 17.46B 5.29B 2024-03
GlaxoSmithKline GBP 13.23B 118M 2024-03
GRIFOLS EUR 5.83B 299.91M 2023-12
Hikma Pharmaceutical USD 2.2B 9M 2023-12
J&J USD 70.02B 1.21B 2024-03
Lonza CHF 9.45B 854M 2023-12
Merck EUR 28.07B 1.39B 2024-03
Merck USD 40.42B 822M 2024-03
Novartis USD 39.76B 6.91B 2024-03
Novartis USD 39.76B 6.91B 2024-03
Orion EUR 707.6M 182.5M 2024-03
Pfizer USD 92.56B 4.38B 2024-03
Philips EUR 12.03B 647M 2023-12
Recordati EUR 1.82B 131.16M 2024-03
Regeneron Pharmaceuticals USD 26.99B 1.02B 2024-03
Roche Holding CHF 29.32B 2.8B 2023-12
UCB EUR 8.98B 67M 2023-12



Novartis Egenkapital Og Reserver - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Jun 2024.